Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis
Sponsor
Assiut University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05060861
Collaborator
(none)
2,000
1
5
403.1
Study Details
Study Description
Brief Summary
Since the beginning of COVID-19 pandemic, a safe and effective vaccine against infection and development of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed control of the wide spread of COVID-19 and reduce death rates throughout the world. Many clinical trials investigated the immunogenicity of different proposed vaccine including the first distributed vaccine; the ChAdOx1 nCoV-19 vaccine and there is a need to analyze the results of published clinical trials.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
2000 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Safety, Efficacy and Immunogenicity of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis
Actual Study Start Date
:
Jun 1, 2021
Actual Primary Completion Date
:
Aug 30, 2021
Anticipated Study Completion Date
:
Oct 30, 2021
Outcome Measures
Primary Outcome Measures
- To evaluate the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis [up to one year]
the frequency of breakthrough COVID-19 infection
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- Participant who received 2 doses of ChAdOx1 nCoV-19 vaccine
Exclusion Criteria:
- non vaccinated person
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Aliae AR Mohamed-Hussein | Assiut | Egypt | 71515 |
Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Aliae AR Mohamed Hussein,
Professor of Pulmonology,
Assiut University
ClinicalTrials.gov Identifier:
NCT05060861
Other Study ID Numbers:
- Assiut19
First Posted:
Sep 29, 2021
Last Update Posted:
Sep 29, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aliae AR Mohamed Hussein,
Professor of Pulmonology,
Assiut University